International Renal Research Institute Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy.
Nephrol Dial Transplant. 2013 Oct;28(10):2553-69. doi: 10.1093/ndt/gft214. Epub 2013 Jun 4.
Peritoneal dialysis (PD) as a modality is underutilized in most parts of the world today despite several advantages including the possibility of it being offered in the remotest of locations and being significantly more affordable than haemodialysis (HD) in most cases. In this article, we will compare the cost of HD and PD in several countries to demonstrate that PD is less than, or at least as expensive as, HD. A thorough literature survey of EMBASE and PUBMED was conducted; 78 articles which compared the annual PD and annual HD costs were finally selected. Careful attention was paid to the methodology followed by each study and the year it was published in. Our final calculations included 46 countries (20 developed and 26 developing). We found that the cost of HD was between 1.25 and 2.35 times the cost of PD in 22 countries (17 developed and 5 developing), between 0.90 and 1.25 times the cost of PD in 15 countries (2 developed and 13 developing), and between 0.22 and 0.90 times the cost of PD in 9 countries (1 developed and 8 developing). From our analysis, it is evident that most developed countries can provide PD at a lesser expense to the healthcare system than HD. The evidence on developing countries is more mixed, but in most cases PD can be provided at a similar cost where economies of scale have been achieved, either by local production or by low import duties on PD equipment.
尽管腹膜透析 (PD) 在许多方面具有优势,例如在最偏远的地区提供透析的可能性,并且在大多数情况下比血液透析 (HD) 更经济实惠,但在当今世界的大多数地区,PD 的使用率仍然较低。在本文中,我们将比较几个国家的 HD 和 PD 的成本,以证明 PD 的费用低于或至少与 HD 相当。我们对 EMBASE 和 PUBMED 进行了全面的文献调查;最终选择了 78 篇比较 PD 和 HD 年度成本的文章。我们仔细关注了每个研究采用的方法和发表年份。我们的最终计算包括 46 个国家(20 个发达国家和 26 个发展中国家)。我们发现,在 22 个国家(17 个发达国家和 5 个发展中国家)中,HD 的成本是 PD 的 1.25 到 2.35 倍;在 15 个国家(2 个发达国家和 13 个发展中国家)中,HD 的成本是 PD 的 0.90 到 1.25 倍;在 9 个国家(1 个发达国家和 8 个发展中国家)中,HD 的成本是 PD 的 0.22 到 0.90 倍。从我们的分析中可以明显看出,大多数发达国家可以以低于 HD 的成本为医疗保健系统提供 PD。发展中国家的证据更为复杂,但在大多数情况下,通过实现规模经济(无论是通过本地生产还是通过对 PD 设备征收低进口关税),都可以以相似的成本提供 PD。